Predictors of chronic kidney disease progression in residents of the Far North

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Objective. Evaluation of the rate of progression of chronic kidney disease (CKD) and identification offactors influencing disease progression in residents of the Far North.

Materials and methods. The study analyzed clinical and laboratory data from 243 CKD patients from the outpatient department of the Noyabrsk Central District Hospital, Yamalo-Nenets Autonomous Okrug, Tyumen Region. Clinical, laboratory, and instrumental parameters were examined. Glomerular filtration rate (GFR) was calculated using the CKD-EPI formula.

Results. The highest rates of CKD progression after 18 months of follow-up were observed in patients aged 45–59 years, in patients with type 2 diabetes mellitus (DM2), in patients with more advanced stages of the disease (C3b–C4), and in patients with poor treatment adherence. Independent predictors of progressive disease progression included creatinine levels greater than 125.4 μmol/L, uric acid levels greater than 0.43 μmol/L, and decreased hemoglobin levels (a 10 g/L decrease increases the likelihood of progression by 17.5%). Signs of accelerated disease progression included age over 74 years, microalbuminuria greater than 287 mg/day, and pulmonary artery systolic pressure greater than 44 mmHg.

Conclusion. The identified signs of progressive and rapidly progressive CKD can be used in the clinical examination of patients living in the Far North.

About the authors

Vladimir A. Zhmurov

Tyumen Medical University

Author for correspondence.
Email: zhmdenis@yandex.ru

Dr.Sci. (Med.), Professor, Head of the Department of Propaedeutics of Internal Disease

Russian Federation, Tyumen

Evgeny Ya. Vanuito

Tyumen Medical University

Email: zhmdenis@yandex.ru

Postgraduate Student, Department of Propaedeutics of Internal Disease

Russian Federation, Tyumen

Denis V. Zhmurov

Tyumen Medical University

Email: zhmdenis@yandex.ru

Cand.Sci. (Med.), Associate Professor, Department of Propaedeutics of Internal Disease

Russian Federation, Tyumen

Ivan M. Petrov

Tyumen Medical University

Email: zhmdenis@yandex.ru

Dr.Sci. (Med.), Associate Professor, Head of the Medical Informatics Department

Russian Federation, Tyumen

Yulianna A. Petrova

Tyumen Medical University

Email: zhmdenis@yandex.ru

Cand.Sci. (Med.), Associate Professor, Department of Propaedeutics of Internal Disease

Russian Federation, Tyumen

Ekaterina A. Zhmurova

Tyumen Medical University

Email: zhmdenis@yandex.ru

Teaching Assistant, Department of Internal Medicine, Outpatient Therapy, and Family Medicine

Russian Federation, Tyumen

Anna A. Ermakova

Tyumen Medical University

Email: zhmdenis@yandex.ru

Teaching Assistant, Department of Propaedeutics of Internal Disease

Russian Federation, Tyumen

Polina A. Ermakova

Tyumen Medical University

Email: zhmdenis@yandex.ru

Assistant Professor, Department of Propaedeutics of Internal Disease

Russian Federation, Tyumen

References

  1. Collaboracion GBDCKD. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33.
  2. Hsiao L.L. et al. Kidney health for all: preparedness for the unexpected in supporting the vulnerable. Kidney Int. 2023;103(3):436–43.
  3. Мухин Н.А. Нефрология. Национальное руководство. Краткое издание. М., 2016. 606 с.
  4. Francis A., Anna et al. Chronic kidney disease and the global public health agenda: an international consensus. Nat. Rev. Nephrol. 2024;20(7):473–85.
  5. Hill N.R., Fatoba S.T. et al. Global prevalence of chronic kidney disease. A systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.
  6. Клинические рекомендации. Хроническая болезнь почек (ХБП). Ассоциация нефрологов. Рубрикатор клинических рекомендаций Минздрава России. 2024. ID: 449. [Clinical guidelines. Chronic kidney disease (CKD). Association of Nephrologists. Rubricator of clinical guidelines of the Ministry of Health of the Russian Federation. 2024. ID: 449 (In Russ.)].
  7. Сигитова О.Н., Богданова А.Р., Саубанова Э.И. Факторы риска, распространенность и темпы прогрессирования хронической болезни почек у амбулаторных пациентов с артериальной гипертензией. Терапия. 2023;65(3);7–4. [Sigitova O. N., Bogdanova A. R., Saubanova E. I. Risk factors, prevalence, and rate of progression of chronic kidney disease in outpatients with arterial hypertension. Therapy. 2023; 65 (3); 7–4 (In Russ.)[.
  8. Шилов Е.М., Сигитова О.Н. Хроническая болезнь почек в практике врачей первичного звена. Терапия. 2023;65(3);106–12. [Shilov E.M., Sigitova O.N. Chronic kidney disease in the practice of primary care physicians. Therapy. 2023; 65 (3); 106–12. (In Russ.)].
  9. Кулаков В.В., Виллевальде С.В., Кобалава Ж.Д. Распространенность нарушений функционального состояния почек у пациентов с артериальной гипертонией в реальной клинической практике. Евразийский кардиологический журнал. 2016;(3):150–151. [Kulakov V. V., Villevalde S. V., Kobalava Zh. D. Prevalence of impaired renal function in patients with arterial hypertension in real-life clinical practice. Eurasian Journal of Cardiology. 2016;(3):150–151 (In Russ.)].
  10. Кобалава Ж.Д., Виллевальде С.В., Боровкова Н.Ю. и др. Распространенность маркеров хронической болезни почек у пациентов с артериальной гипертонией: результаты эпидемиологического исследования ХРОНОГРАФ. Кардиология. 2017;57(10):39–44. [Kobalava Zh.D., Villevalde S.V., Borovkova N.Yu., et al. Prevalence of markers of chronic kidney disease in patients with arterial hypertension: results of the CHRONOGRAPH epidemiological study. Cardiology. 2017;57(10):39–44. (In Russ.)].
  11. Зуева Т.В., Жданова Т.В. Артериальная гипертензия при хронической болезни почек: современное состояние проблемы. Лечащий врач.2020;(9):11–14. [Zueva T.V., Zhdanova T.V. Arterial hypertension in chronic kidney disease: the current state of the problem. Attending physician. 2020;(9):11–14. (In Russ.)].
  12. Жмуров В.А., Осколков С.А., Казеко Н.И. Хронический пиелонефрит у жителей различных климато-географических регионов. Тюмень, 2006. 304 с. [Zhmurov V.A., Oskolkov S.A., Kazeko N.I. Chronic pyelonephritis in residents of different climatic and geographical regions. Tyumen, 2006. 304 p. (In Russ.)].
  13. Жмуров В.А., Осколков С.А., Четвертков В.А., Афлетунов В.Н. Тубуло-интерстициальные заболевания почек у жителей Приполярного Севера и Заполярья. Тюмень, 2012. 132 с. [Zhmurov V.A., Oskolkov S.A., Chetvertkov V.A., Afletunov V.N. Tubulointerstitial kidney diseases in residents of the Subpolar North and Arctic Circle. Tyumen, 2012. 132 p. (In Russ.)].
  14. Hunsicker L.G., Lawrence G. et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51(6):1908–19.
  15. Tangri N., Navdeep et al. A predictive model for progression of chronic kidney disease to kidney failure. Jama. 2011;305(15)1553–9.
  16. Kelly K.J., Dominguez J.H. Rapid progression of diabetic nephropathy is linked to inflammation and episodes of acute renal failure. Am. J. Nephrol. 2010;32(5):469–75.
  17. Земченков А.Ю., Конакова И.Н. Темпы прогрессирования хронической болезни почек по данным Санкт-Петербургского городского регистра ХБП. Нефрология и диализ. 2015;17(1):34–51. [Zemchenkov A.Yu., Konakova I.N. Progression rates of chronic kidney disease according to data from the St. Petersburg City Registry of CKD. Nephrology and Dialysis. 2015;17(1):34–51 (In Russ.)].
  18. Jones C., Chris et al. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol. Dial. Transplantat. 2006;21(8):2133–43.
  19. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023;26(2);104–23. [Dedov I.I., Shestakova M.V., Vikulova O.K. et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to data from the Federal Registry of Diabetes Mellitus for the period 2010–2022. Diabetes Mellitus. 2023;26(2);104–23 (In Russ.)].
  20. Муркамилов И.Т., Айтбаев К.А., Фомин В.В. Распространенность, возрастные и гендерные особенности хронической болезни почек у больных сахарным диабетом. Терапевтический архив. 2023;95(6):481–486. [Murkamilov I.T., Aitbaev K.A., Fomin V.V. Prevalence, age and gender characteristics of chronic kidney disease in patients with diabetes mellitus. Therapeutic archive. 2023;95(6):481–486 (In Russ.)].
  21. Wu H.Y., Huang J.W. et al. Comparative effectiveness of renin-angiotensin system blokers and other antihypertensive drugs in patients with diabetes: systematic revive and Bayesian network meta-analysis. BMJ. 2013;347:f6008. doi: 10.1136/bmj.f6008.
  22. Catala-Lopez F., Macias Saint-Gerons D. et al. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blokade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses. PL0S Med. 2016;13(3):e1001971. doi: 10.1371/journal.pmed.1001971.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).